Total Reports
11
FDA CVM filings
Dog /
FDA CVM · 2025 release 11 reports on file
New Guinea Singing Dog - FDA Adverse Event Profile
Adverse-event records for New Guinea Singing Dog (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
New Guinea Singing Dog's FDA record: #430 most-reported dog breed, 11 total reports, 0.0% death-coded (0 reports).
- #430
- most-reported dog breed
- 0.0%
- death-coded report share
- 2
- Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
- 5.0 yr
- average age at report
Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.
Deaths Reported
0
of 11 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
5.0 yr
no age data
Death-Coded Outcome Share
New Guinea Singing Dog death-coded reports 0.0%
Cross-breed median
0.0% of 11 new guinea singing dog reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Top Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy (endoparasite) - heartworm 2
INEFFECTIVE, ATOPY CONTROL 1
Inappropriate schedule of drug administration 1
Skin lesion NOS 1
Most Referenced Drugs
Moxidectin 5
Oclacitinib Maleate 2
Butorphanol 2
Anti-Il31 Mab Mcs Lot #1283563 1
Canine Parvovirus Strain Nl-35-D, P.35-D, 8-2-80;Canine Parainfluenza Virus, Str 1
Outcome Breakdown
Recovered/Normal
5 (45.5%)
Ongoing
4 (36.4%)
Outcome Unknown
2 (18.2%)
Gender Distribution
Unknown 11 (100.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2018 | 1 | |
| 2019 | 3 | |
| 2020 | 3 | |
| 2021 | 4 | |
New Guinea Singing Dog Pet Health Insights
New Guinea Singing Dog accounts for 11 FDA adverse event reports, ranking #430 by volume among dog breeds, with 0 reports (0.0%) coded as a death outcome. Mean age at report: 5.0 years.
Top reported signs: Lethargy (see also Central nervous system depression in 'Neurological') (2), Lack of efficacy (endoparasite) - heartworm (2), INEFFECTIVE, ATOPY CONTROL (1). Most-referenced drug: Moxidectin (5 reports), followed by Oclacitinib Maleate (2) and Butorphanol (2).
Outcome coding on 11 status-recorded reports is dominated by Recovered/Normal (45.5%). Annual submissions ranged 2,018-2,021 across 4 years on file.
Dog Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve New Guinea Singing Dog? ▼
There are 11 adverse event reports involving New Guinea Singing Dog in the FDA database, with 0 reports involving death (0.0% death rate). New Guinea Singing Dog ranks #430 by report volume.
What are the most common adverse reactions reported for New Guinea Singing Dog? ▼
The most commonly reported adverse reactions for New Guinea Singing Dog are Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Lack of efficacy (endoparasite) - heartworm (2 reports), INEFFECTIVE, ATOPY CONTROL (1 reports), Inappropriate schedule of drug administration (1 reports), Skin lesion NOS (1 reports).
What drugs are most frequently associated with New Guinea Singing Dog adverse events? ▼
The drugs most frequently referenced in New Guinea Singing Dog adverse event reports are Moxidectin (5 reports), Oclacitinib Maleate (2 reports), Butorphanol (2 reports), Anti-Il31 Mab Mcs Lot #1283563 (1 reports), Canine Parvovirus Strain Nl-35-D, P.35-D, 8-2-80;Canine Parainfluenza Virus, Str (1 reports).
What is the average age of New Guinea Singing Dog in adverse event reports? ▼
The average age of New Guinea Singing Dog at the time of adverse event reports is 5.0 years.
Does a high number of adverse event reports mean New Guinea Singing Dog is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this New Guinea Singing Dog safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.